pharmaceutical composition, methods to prevent or treat niacin-induced flushing in an individual, to reduce at least one niacin therapy-related flushing symptom in an individual, to decrease protaglandin-related side effects in an individual, to decrease a rate of discontinuation of niacin treatment by an individual, to increase patient compliance with niacin treatment, to treat atherosclerosis in a patient, to treat a disease related to a low hdl profile in a patient, nicotinic acid formulation of modified dispensing, pharmaceutical composition use, and aspirin microcapsule

摘要

pharmaceutical composition, methods to prevent or treat niacin-induced flushing in an individual, to reduce at least one niacin therapy-related flushing symptom in an individual, to decrease prostaglandin-related side effects in an individual, to decrease a rate of discontinuation of niacin treatment by an individual, to increase patient compliance with niacin treatment, to treat atherosclerosis in a patient, to treat a disease related to a low hdl profile in a patient, nicotinic acid formulation of Modified dispensing, use of the pharmaceutical composition, and aspirin and niacin microcapsules Pharmaceutical compositions and methods for preventing or reducing niacin-induced flush comprising an aspirin component and a niacin component having different dispensing profiles are provided. Also provided are methods and compositions for preventing or reducing niacin-induced flushing comprising niacin, aspirin and a lipid lowering medicament other than niacin.